









Markets
/
Stocks
/
nasdaq-sgmt
/

Sagimet Biosciences Inc

SGMT

6.240USD

-0.040-0.64%

Close 12/22, 16:00（ET）Quotes delayed by 15 min

202.93MMarket Cap

LossP/E TTM



Sagimet Biosciences Inc

6.240

-0.040-0.64%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Sagimet Biosciences Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q2

FY2022Q1

FY2021Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

47.98%-10.18M

-61.54%-9.10M

-134.15%-14.54M

-55.64%-11.02M

-404.49%-19.57M

1.50%-5.63M

12.37%-6.21M

---7.08M

---3.88M

6.81%-5.72M

-51.85%-7.08M

---6.14M

-79.56%-4.67M

---2.60M

Net income from continuing operations

11.70%-12.91M

-27.94%-10.39M

-174.19%-18.18M

-98.76%-16.20M

-130.11%-14.62M

-19.65%-8.12M

-0.64%-6.63M

---8.15M

---6.35M

4.46%-6.79M

24.59%-6.59M

---7.10M

-119.31%-8.73M

---3.98M

Other non-cash items

169.18%339.00K

57.47%-188.00K

-215.92%-496.00K

-150.00%-19.00K

-1500.00%-490.00K

-1573.33%-442.00K

-15600.00%-157.00K

--38.00K

--35.00K

433.33%30.00K

-103.13%-1.00K

---9.00K

6.67%32.00K

--30.00K

Change in working capital

111.67%701.00K

-108.46%-125.00K

1571.82%2.66M

1426.81%3.66M

-1128.42%-6.01M

7133.33%1.48M

85.69%-181.00K

---276.00K

--584.00K

-103.56%-21.00K

-134.63%-1.27M

--590.00K

257.79%3.65M

--1.02M

-Change in prepaid expenses

80.85%-825.00K

-108.58%-35.00K

-207.34%-687.00K

679.36%3.26M

-463.27%-4.31M

-0.97%408.00K

1829.73%640.00K

---562.00K

---765.00K

520.41%412.00K

-102.39%-37.00K

---98.00K

890.38%1.54M

--156.00K

-Change in payables and accrued expense

194.16%1.56M

-104.67%-51.00K

533.50%3.39M

38.75%444.00K

-219.42%-1.66M

374.81%1.09M

34.45%-782.00K

--320.00K

--1.39M

-155.99%-397.00K

-155.33%-1.19M

--709.00K

140.63%2.16M

--896.00K

-Change in other current liabilities

----

--4.00K

---4.00K

----

Cash from non-recurring investing activities

Cash from operating activities

47.98%-10.18M

-61.54%-9.10M

-134.15%-14.54M

-55.64%-11.02M

-404.49%-19.57M

1.50%-5.63M

12.37%-6.21M

---7.08M

---3.88M

6.81%-5.72M

-51.85%-7.08M

---6.14M

-79.56%-4.67M

---2.60M

Investing cash flow

Net cash flow from investment products

-87.98%75.00K

82.32%-13.29M

13.77%3.41M

150.20%9.85M

--624.00K

-687.16%-75.16M

-84.54%3.00M

---19.62M

--0.00

--12.80M

--19.40M

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-87.98%75.00K

82.32%-13.29M

13.77%3.41M

150.20%9.85M

--624.00K

-687.16%-75.16M

-84.54%3.00M

---19.62M

--0.00

130.88%12.80M

--19.40M

---41.45M

--0.00

----

Financing cash flow

Cash flow from continuous financing activities

--274.00K

103.70%1.00K

-100.00%0.00

--0.00

-100.00%0.00

97.03%-27.00K

77192.65%104.85M

--0.00

--87.21M

-2933.33%-910.00K

-1233.33%-136.00K

---30.00K

--12.00K

--0.00

Net cash flow from common stock issuance/repurchase

--0.00

-100.00%0.00

--0.00

--105.75M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

Proceeds from stock option exercised by employees

--274.00K

--1.00K

-100.00%0.00

--0.00

-100.00%0.00

--0.00

--114.00K

--0.00

--6.00K

--0.00

-100.00%0.00

--0.00

--12.00K

--0.00

Net cash flow from other financing activities

--0.00

100.00%0.00

--0.00

-100.00%0.00

97.03%-27.00K

-648.53%-1.02M

--0.00

--87.21M

-2933.33%-910.00K

---136.00K

---30.00K

--0.00

----

Net cash from non-recurrent financing activities

Net cash from financing activities

--274.00K

103.70%1.00K

-100.00%0.00

--0.00

-100.00%0.00

97.03%-27.00K

77192.65%104.85M

--0.00

--87.21M

-2933.33%-910.00K

-1233.33%-136.00K

---30.00K

--12.00K

--0.00

Net cash flow

Beginning cash balance

-55.89%42.33M

-63.39%64.72M

0.93%75.84M

-24.38%77.01M

418.47%95.96M

1332.78%176.78M

47456.33%75.14M

--101.84M

--18.51M

-76.31%12.34M

-99.72%158.00K

--52.08M

455.53%56.73M

--10.21M

Current period cash flow changes

48.11%-9.83M

72.30%-22.39M

-110.94%-11.12M

95.60%-1.17M

-122.73%-18.95M

-1409.85%-80.82M

734.47%101.64M

---26.70M

--83.33M

112.96%6.17M

361.77%12.18M

---47.61M

-79.10%-4.65M

---2.60M

Ending cash balance

-57.81%32.50M

-55.89%42.33M

-63.39%64.72M

0.93%75.84M

-24.38%77.01M

418.47%95.96M

1332.78%176.78M

--75.14M

--101.84M

314.61%18.51M

-76.31%12.34M

--4.46M

583.98%52.08M

--7.61M

Free cash flow

47.98%-10.18M

-61.54%-9.10M

-134.15%-14.54M

-55.64%-11.02M

-404.49%-19.57M

1.50%-5.63M

12.37%-6.21M

---7.08M

---3.88M

---5.72M

-51.85%-7.08M

----

---4.67M

----

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

